Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

Safety Information

294837

Sigma-Aldrich

Hydrogen chloride solution

1.0 M in diethyl ether

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
HCl
CAS Number:
7647-01-0
Molecular Weight:
36.46
MDL number:
MFCD00011324
UNSPSC Code:
12352301
PubChem Substance ID:
329753358
NACRES:
NA.21

form

liquid

Quality Level

100

concentration

0.95-1.10 M (with NaOH, titration)
1.0 M in diethyl ether

density

0.731 g/mL at 25 °C

storage temp.

2-8°C

SMILES string

Cl

InChI

1S/ClH/h1H

InChI key

VEXZGXHMUGYJMC-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

Hydrogen chloride solution (1.0 M in diethyl ether) is generally prepared by passing HCl gas through diethyl ether solvent. It is suitable for air/moisture-sensitive reactions.

Application

Hydrogen chloride solution (1.0 M in diethyl ether) can be used in the synthesis of molybdenum adamantylimido and t-butylimido alkylidene chloride complexes in the presence of PPh2Me. It is also used in some cyclization reactions, for example, in the cyclization of oxadiazole derivatives from corresponding thiosemicarbazides.

Signal Word

Danger

Hazard Statements

H225,H290,H302,H336

Hazard Classifications

Acute Tox. 4 Oral - Flam. Liq. 2 - Met. Corr. 1 - STOT SE 3

Target Organs

Central nervous system

Supplementary Hazards

EUH019,EUH066

Storage Class Code

3 - Flammable liquids

WGK

WGK 1

Flash Point(F)

-40.0 °F - closed cup

Flash Point(C)

-40 °C - closed cup

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

FSL

Group 4: Flammable liquids
Type 1 petroleums
Hazardous rank II
Water insoluble liquid

ISHL Indicated Name

Substances Subject to be Indicated Names

ISHL Notified Names

Substances Subject to be Notified Names

JAN Code

294837-4X100ML:4548173953205
294837-800ML:4548173131245
294837-VAR:
294837-100ML:4548173131238
294837-BULK:

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Xuan Zhang et al.
Nanomedicine : nanotechnology, biology, and medicine, 11(6), 1365-1375 (2015-04-19)
Intratumoral injection of ultra-small gold nanoparticles (AuNPs) conjugated to doxorubicin (Au-Dox) is effective against both murine B16 and human SK-MEL-28 tumors in mice. Au-Dox suppresses growth of B16 tumors in immunocompetent mice by >70% for at least 19 days. In
Thomas Krohn et al.
European journal of nuclear medicine and molecular imaging, 42(2), 210-214 (2014-09-25)
To determine the frequency of seemingly pathological retroperitoneal uptake in the location of the coeliac ganglia in patients undergoing [(68)Ga]PSMA-HBED PET/CT. The study included 85 men with prostate cancer referred for [(68)Ga]PSMA-HBED PET/CT. The PET/CT scans were evaluated for the
Jay G Hosking et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(4), 1005-1015 (2014-10-21)
Successful decision making often requires weighing a given option's costs against its associated benefits, an ability that appears perturbed in virtually every severe mental illness. Animal models of such cost/benefit decision making overwhelmingly implicate mesolimbic dopamine in our willingness to
Ann Brinkmalm et al.
Molecular neurodegeneration, 9, 53-53 (2014-11-25)
Synaptic degeneration is an early pathogenic event in Alzheimer's disease, associated with cognitive impairment and disease progression. Cerebrospinal fluid biomarkers reflecting synaptic integrity would be highly valuable tools to monitor synaptic degeneration directly in patients. We previously showed that synaptic
Dominik Theler et al.
Nucleic acids research, 42(22), 13911-13919 (2014-11-13)
N(6)A methylation is the most abundant RNA modification occurring within messenger RNA. Impairment of methylase or demethylase functions are associated with severe phenotypes and diseases in several organisms. Beside writer and eraser enzymes of this dynamic RNA epigenetic modification, reader
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service